Pulse Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Robert W. Duggan has increased his beneficial ownership in Pulse Biosciences, Inc. to approximately 71.9% following recent share acquisitions.